BlackRock Group’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $48K | Hold |
10,870
| – | – | ﹤0.01% | 2905 |
|
|
2016
Q3 | $62K | Hold |
10,870
| – | – | ﹤0.01% | 2872 |
|
|
2016
Q2 | $70K | Hold |
10,870
| – | – | ﹤0.01% | 2848 |
|
|
2016
Q1 | $91K | Hold |
10,870
| – | – | ﹤0.01% | 2776 |
|
|
2015
Q4 | $111K | Hold |
10,870
| – | – | ﹤0.01% | 2655 |
|
|
2015
Q3 | $128K | Hold |
10,870
| – | – | ﹤0.01% | 2634 |
|
|
2015
Q2 | $212K | Sell |
10,870
-44,207
| -80% | -$862K | ﹤0.01% | 2547 |
|
|
2015
Q1 | $980K | Hold |
55,077
| – | – | ﹤0.01% | 1872 |
|
|
2014
Q4 | $1.01M | Hold |
55,077
| – | – | ﹤0.01% | 1854 |
|
|
2014
Q3 | $1.33M | Buy |
55,077
+11,320
| +26% | +$274K | ﹤0.01% | 1602 |
|
|
2014
Q2 | $1.6M | Hold |
43,757
| – | – | ﹤0.01% | 1560 |
|
|
2014
Q1 | $2M | Hold |
43,757
| – | – | ﹤0.01% | 1550 |
|
|
2013
Q4 | $1.7M | Hold |
43,757
| – | – | ﹤0.01% | 1617 |
|
|
2013
Q3 | $1.98M | Buy |
43,757
+16,090
| +58% | +$729K | ﹤0.01% | 1462 |
|
|
2013
Q2 | $1.36M | Buy |
+27,667
| New | +$1.36M | ﹤0.01% | 1519 |
|